Page last updated: 2024-08-25

3-amino-1,2,4-benzotriazine-1-oxide and Lung Neoplasms

3-amino-1,2,4-benzotriazine-1-oxide has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, JM; Hay, MP; Hogg, A; Pruijn, FB; Siim, BG; Sturman, JR; Wilson, WR1

Other Studies

1 other study(ies) available for 3-amino-1,2,4-benzotriazine-1-oxide and Lung Neoplasms

ArticleYear
Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
    Cancer research, 2004, Jan-15, Volume: 64, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Synergism; Female; Humans; Lung Neoplasms; Mice; Pharyngeal Neoplasms; Tirapazamine; Triazines; Uterine Cervical Neoplasms

2004